文献速递心脑血管急症重症综合管理与镇静镇痛

非增强CT评分预测脑出血血肿扩大的验证与比较

Validation and Comparison of Noncontrast CT Scores to Predict Intracerebral Hemorrhage Expansion.
PubMed 文献 · Neurocrit Care · 2020-01-01
一句话结论BAT、BRAIN、HEP评分仅用基线非增强CT即可预测脑出血血肿扩大,区分度可接受,BAT≥3特异性最高(0.81),BRAIN≥6敏感性最高(0.76)。

该研究回顾性分析两个队列共230例原发性脑出血患者,血肿扩大定义为体积增长>33%或>6 mL,86例(37.4%)发生血肿扩大。两名评估者盲法分析非增强CT并计算BAT、BRAIN、HEP评分。血肿扩大的AUC分别为BAT 0.696、BRAIN 0.700、HEP 0.648,各评分间无显著差异(均p>0.4),校准良好(均p>0.3),评估者间信度良好至优秀(组内相关系数>0.8)。BAT≥3特异性最高(0.81),BRAIN≥6敏感性最高(0.76)。作者认为这些工具可用于临床实践或随机对照试验中对血肿扩大风险进行分层。

要点

  • BAT、BRAIN、HEP评分仅需基线非增强CT即可预测脑出血血肿扩大,AUC分别为0.696、0.700、0.648,各评分间无显著差异(均p>0.4)。
  • BAT≥3特异性最高(0.81),BRAIN≥6敏感性最高(0.76),可根据床旁需求选择侧重排除或筛查的评分。
  • 所有评分校准良好(均p>0.3),评估者间信度良好至优秀(组内相关系数>0.8),两名评估者盲法独立评分。
  • 血肿扩大定义为体积增长>33%或>6 mL,230例中86例(37.4%)发生血肿扩大。
  • 作者认为这些工具可用于临床实践或随机对照试验中对血肿扩大风险进行分层。

适用人群与场景

  • 原发性脑出血患者,来自两个回顾性队列,共230例,其中86例(37.4%)发生血肿扩大。

诊断标准与关键阈值

  • 血肿扩大定义为体积增长>33%或>6 mL。
  • BAT评分≥3、BRAIN评分≥6为原文通过约登指数识别的二分类切点。

研究设计与关键结果

  • 研究类型为对两个原发性脑出血患者队列的回顾性分析,共230例,86例(37.4%)发生血肿扩大;两名评估者盲法分析非增强CT并计算BAT、BRAIN、HEP评分。
  • 血肿扩大的AUC:BAT 0.696、BRAIN 0.700、HEP 0.648;各评分间AUC无显著差异(均p>0.4)。
  • 所有评分校准良好(均p>0.3),评估者间信度良好至优秀(组内相关系数>0.8)。
  • BAT≥3特异性最高(0.81),BRAIN≥6敏感性最高(0.76)。

证据类型、等级与局限

  • 证据类型:对两个原发性脑出血患者队列的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为BAT、BRAIN、HEP评分可用于临床实践或随机对照试验中对血肿扩大风险进行分层。
  • BAT≥3特异性最高(0.81),BRAIN≥6敏感性最高(0.76),可根据床旁侧重选择评分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: The BAT, BRAIN, and HEP scores have been proposed to predict hematoma expansion (HE) with noncontrast computed tomography (NCCT). We sought to validate these tools and compare their diagnostic performance.

METHODS: We retrospectively analyzed two cohorts of patients with primary intracerebral hemorrhage. HE expansion was defined as volume growth > 33% or > 6 mL. Two raters analyzed NCCT scans and calculated the scores, blinded to clinical and imaging data. The inter-rater reliability was assessed with the interclass correlation statistic. Discrimination and calibration were calculated with area under the curve (AUC) and Hosmer-Lemeshow χ2 statistic, respectively. AUC comparison between different scores was explored with DeLong test. We also calculated the sensitivity, specificity, positive, and negative predictive values of the dichotomized scores with cutoffs identified with the Youden's index.

RESULTS: A total of 230 subjects were included, of whom 86 (37.4%) experienced HE. The observed AUC for HE were 0.696 for BAT, 0.700 for BRAIN, and 0.648 for HEP. None of the scores had a significantly superior AUC compared with the others (all p > 0.4). All the scores had good calibration (all p > 0.3) and good-to-excellent inter-rater reliability (interclass correlation > 0.8). BAT ≥ 3 showed the highest specificity (0.81), whereas BRAIN ≥ 6 had the highest sensitivity (0.76).

CONCLUSIONS: The BAT, BRAIN, and HEP scores can predict HE with acceptable discrimination and require just a baseline NCCT scan. These tools may be used to stratify the risk of HE in clinical practice or randomized controlled trials.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Poli L, Leuci E, Costa P, et al. Validation and Comparison of Noncontrast CT Scores to Predict Intracerebral Hemorrhage Expansion. Neurocrit Care. 2020. PMID: 31342451. doi:10.1007/s12028-019-00797-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。